| |
During the past few
decades, particularly since World War II, viral hepatitis has become
an increasingly important public health problem throughout the world.
Viral hepatitis is one of the commonest causes of jaundice in children
and is one of the diseases still unconquered even in the West. In
recent years, there has been a better understanding of the epidemiology
and clinical picture of the disease which has helped in the formulation
of control measures. However, in the absence of isolation of the
specific virus and specific serological diagnosis, many lacunae
in our knowledge still persist. Infective hepatitis is endemic in
most of the urban areas in India. Large number of epidemics have
been investigated and reported in recent years. (Mehta and Acharya,
1973). Aurangabad is an area of endemic hepatitis. Dhamahere and
Nadkarni (1962) reported water-borne epidemic of infective hepatitis
in part of Aurangabad city. As a general rule, infective hepatitis
is a mild disease with low mortality. However, the commonest cause
of death in this disease is acute liver failure leading to coma
and death. In children, its course is usually mild but can lead
to post-hepatic cirrhosis, chronic cholestasis, subacute necrosis
and hepatic failure. The chances of such complications are high,
particularly in our country, where malnutrition is extremely rampant
(Rao et al., 1975). Viral hepatitis in children has many
interesting facets. Of particular interest is its possible relationship
to Indian childhood cirrhosis (Madhavan et al., 1973); a
theory of viral aetiology (Achar et al., 1960, Chandra, 1970)
is based on a frequent occurrence of jaundice at the onset, history
of jaundice and hepatitis - like illness in other family members
and clinical resemblance of the acute fulminant variety to submassive
necrosis of the liver seen in infective hepatitis.
There is no specific
therapy for viral hepatitis and evaluation of any drug in the treatment
of infective hepatitis is difficult as it is a variable disease.
There are many clinical types having a variable course and prognosis.
However, a drug which can restore liver function quickly without
producing harmful effects and is reasonably inexpensive is most
welcome. Various reports of corticoid therapy are available (Evans
et al., 1953; Huber and Willey, 1956; Vakil et al.,
1965; Vakil, 1973). However of late, there have been number of reports
about the efficacy of Liv.52 in this disease (Arora, 1961. Ramalingam
et al., 1971, Sule et al., 1961, Mitra et al.,
1974, Rao et al., 1975).
We present a clinical profile
of viral hepatitis in children from Aurangabad.
One hundred and thirty
cases of viral hepatitis admitted to the Medical College Hospital,
Aurangabad, during the period January 1972 to July 1975, were studied.
The majority of cases were admitted in the summer months. A detailed
clinical history was recorded, physical examination and routine
laboratory investigations such as complete blood picture, urinalysis
for bile salts, bile pigments, urobilinogen and liver function tests,
which included serum bilirubin, serum transaminases etc. were done.
Liver biopsy could be done only in 40% of cases on admission and
it could not be repeated after treatment in any of the cases.
The ages of these children ranged from
5 months to 12 years: the highest incidence being in the age group
4-7 years. (Table 1). Sixty-five percent belonged to the poor socio-economic
group, 20% to the middle income and the rest to the high income group.
|
Table 1: Age distribution
of infective hepatitis cases
|
|
Age
|
No. of cases
|
Percentage
|
|
Below 1 year
|
10
|
7.7
|
|
1 - 3 years
|
35
|
27.0
|
|
4 - 7 years
|
45
|
34.6
|
|
8 - 12 years
|
40
|
30.7
|
Jaundice lasted for less than 10 days prior to admission
in 50% of cases and 10-20 days in 30.7% of cases (Table 2).
|
Table
2: Duration of jaundice prior to admission
|
|
Duration
|
No.
of cases
|
Percentage
|
| Less
than 10 days |
65
|
50.0
|
| 10
- 20 days |
40
|
30.7
|
| 21
- 30 days |
15
|
11.6
|
| More
than 30 days |
10
|
7.7
|
|
Total
|
130
|
100.0
|
|
Table 3: Complaints on admission
|
|
Complaints
|
No. of cases
|
Percentage
|
| Lack of
appetite |
130
|
100.0
|
| Fever |
100
|
77.0
|
| Yellow
urine |
125
|
96.1
|
| Jaundice |
80
|
61.5
|
| Clay coloured
stool |
65
|
50.0
|
| Nausea
or vomiting |
40
|
30.7
|
| Pain in
abdomen |
50
|
42.3
|
| Insomnia |
15
|
11.6
|
| Chills
and rigors |
10
|
7.7
|
| Bleeding
tendencies |
5
|
3.8
|
Sudden onset of loss of appetite was the most frequent
complaint, and jaundice was noticed by mothers in 61.5 percent cases,
the time of appearance of jaundice varying from 2-6 days after loss
of appetite. Fever was present in 77 percent and yellow urine was
noticed by the mothers in 96.1 percent cases. Ten cases (7.7%) presented
with fever, chills and rigors and were mistaken for malaria on admission.
None of the cases presented with coma.
Liver was enlarged in 97 percent of cases, the hepatomegaly
ranging from 1-6 cm. below the costal margin in the midclavicular
line. Tenderness was present in 70 percent of cases although it
was difficult to assess tenderness in infants below 1 year. Lymph
nodes were enlarged in 22% of cases. Ascites was observed in 3%
of cases and bradycardia was detected in 1.5 percent of cases.
Serum bilirubin levels ranged from 2-10mg% and alkaline
phosphatase levels from 10-25 Kingsley Armstrong units. Elevated
levels of serum glutamic oxaloacetic and pyruvic transaminases (SGOT
and SGPT) were found in 90 percent cases. Graph I shows the mean
levels of serum bilirubin, SGOT, SGPT in these children at weekly
intervals.
The histopathological changes in the liver included
vacuolation of hepatocytes in varying degrees with scanty and granular
cytoplasm. The portal tracts were infiltrated with mononuclear cells
and segmented leucocytes. Focal areas of necrosis were observed
in most of the cases studied. Cholestasis with bile pigment in hepatocytes
and biliary canaliculi was found in a few cases.
The majority of the cases were treated with Liv.52
(2 teaspoonfuls twice a day upto 2 years of age, 2 teaspoonfuls
thrice a day from 2-10 years of age and 2 tablets thrice a day to
cases between 10-12 years). Only a few cases were treated with prednisone
1-2mg/kg for 1-2 weeks. There were 5 cases who could not survive
due to development of hepatic coma.
Infective hepatitis is
a systemic viral disease with predominant involvement of the liver.
It is a disease of varying severity ranging from mild anicteric
hepatitis to acute fulminating hepatitis leading to precoma and
coma. The disease is widely prevalent in India. In the Marathwada
region it is endemic with periodic outbreaks of epidemics, especially
in the summer and early rainy season.
Infective hepatitis is
caused by hepatitis virus ‘A’. It occurs endemically and more characteristically
in epidemics in institutions, schools and in military camps. The
virus is excreted in the faeces and infection follows the ingestion
of contaminated food; under conditions of community living, spread
is facilitated and epidemics may occur. Viral hepatitis may be caused
by hepatitis virus ‘B’ (serum hepatitis) in hospitals and clinics
where syringes and needles are used without sterilisation before
each inoculation. It has been well proved that serum hepatitis can
also be transmitted by the orofaecal route and hepatitis ‘A’ infection
by transfusion. Both the types of hepatitis have indistinguishable
clinical manifestations which may vary from severe to mild and silent
forms. In both, the virus has been shown to be present in the blood
in the presymptomatic period. It is therefore apparent that blood
from supposedly normal donors who have never had hepatitis may yet
contain virus A or virus B or both.
There is strong circumstantial
evidence that Australia (Au) antigen is a surface antigen of serum
hepatitis (SH) virus which is mildly infectious and which can be
transmitted by contagion (Krugman et al., 1967). At present
detection of Au (Hepatitis-Associated) antigen is the only simple
means available for detecting the SH virus. In the United States,
urban endemic hepatitis, particularly in adults, is largely caused
by the SH virus (Prince et al., 1970). Data are meagre (Hills
et al., 1970); Sehgal and Aikat, 1970; Sama et al.,
1971; Sundaravalli, et al., 1971; Kelkar et al., 1973,
a, b).
Laboratory acquired infection
(Epigastric hepatitis)—endemic hepatitis can occur in laboratory
personnel working with materials containing the hepatitis B virus
(Sutnick et al., 1971). In India, hepatitis B infection was
noted by Baxi (1973) and Mahajan et al., (1974).
Viral hepatitis is often
a self-limiting disease, but can have high mortality and morbidity
during an epidemic (Melnick, 1957), particularly where malnutrition
is endemic. Therapy with an inexpensive and efficient drug is, therefore,
welcome. Peak incidence in the present study was in the pre-school
age group, an observation made by other workers (Dave et al.,
1972; Rao et al., 1975). The higher frequency noted in our
study during the summer months also agrees with the observation
of other workers (Viswanathan, 1957; Rao et al., 1975; Mitra
et al., 1974). Lack of appetite with irritability and fever
should alert the physician for the development of jaundice, in a
few days and urine examination for bile salts, bile pigments and
urobilinogen should be a routine in such cases. Early detection
is of importance, to avoid administration of hepatotoxic drugs,
such a chlorpromazine, etc. for vomiting, or drugs such as cyprohepatadine
hydrochloride for appetite. Abdominal pain was noticed in 42.3 percent;
this is in agreement with the observations of Sule et al.,
(1968). It is attributed to perihepatitis, distension of Glisson’s
capsule, phlegmonous enteritis or sudden shrinkage of liver in acute
hepatic necrosis (Litchman, 1953).
In the present study
Liv.52 was given in the majority of cases in view of our previous
experience (Mitra et al., 1974). However, corticosteroids
were given a few cases including 5 cases of coma. No control trial
of Liv.52 was done in the present study as we have recently reported
our experiences from this institution. (Mitra et al., 1974).
The efficacy of Liv.52 was observed by several other workers (Arora,
1961, Ramalingam et al., 1971, Dave et al, 1972, Deshpande
and Sheth, 1972). We feel from our experiences that the absence
of untoward side-effects with even prolonged administration makes
this drug safe and effective in the management of viral hepatitis
in children.
In the Marathwada region
of Maharashtra viral hepatitis is endemic with periodic outbreaks
of epidemics, especially in the summer and early rainy season.
One hundred and thirty
cases of viral hepatitis in children admitted to Medical College
Hospital, Aurangabad were studied. The ages of these children ranged
from 5 months to 12 years the highest incidence was in the age group
4-7 years the majority of them (65%) belonged to the poor socio-economic
group. Jaundice had lasted for less than 10 days prior to admission
in 50% of cases. Mortality rate was 3.8%. Complete biochemical recovery
took 8-10 weeks in the majority of the cases.
- Arora, J.K., Role of various types of treatment in infective
hepatitis, Armed Forces med. J. (1961): 3, 3621.
- Achar, S.T., Raju, V.b. and Sriramachari, S., Indian childhood
cirrhosis, J. Pediat. (1960): 57, 744.
- Baxi, A. (1973) —quoted by Mahajan et al. (1974).
- Chandra, R.K., Immunological picture in Indian childhood cirrhosis,
Lancet (1970): 1, 537.
- Dave, D.S., Rajput, V.J. and Gupta, N.R., Clinico-biochemical
study of infective hepatitis, Probe (1972): 911, 214.
- Dhamdhere, M.R. and Nadkarni, M.G., Infective hepatitis at Aurangabad,
Ind. J. med. Sci. (1962): 61, 1006.
- Deshpande, R.S. and Seth, S.C., Infective hepatitis, Study of
100 cases, Probe (1972): 11, 105.
- Evans, A.S. Sprinz, H. and Nelson, R.S., Adrenal hormone therapy
in viral hepatitis, Ann. Intern. Med. (1953): 38, 1115.
- Hillis, W.D., Pathanayak, S. and Arora, D.D., Detection of Australia
antigen in human viral hepatitis, Ind. J. med. Res. (1970):
58, 1172.
- Huber, T.E. and Willey, A.T., Cortisone in the treatment of
infective hepatitis, Ann. Intern. Med. (1965): 42, 1011.
- Kelkar, S.S., Niphadkar, K.B., Khare, P.M., Titres of Australia
(Hepatitis - Associated) Antigen in healthy carriers, cirrhosis
of the liver and acute hepatitis, Ind. J. Med. Res. (1973a):
61, 684.
- Kelkar, S.S., Niphadkar, K.B. and Karve, S.R. Australia (Hepatitis
Associated) Antigen in urban endemic hepatitis at Poona, Ind.
J. Med. Res. (1973b): 61, 482.
- Litchman, S.S., in diseases of liver and Gall bladder, 3rd ed.
Lea & Febiger, Philadelphia, 1953.
- 14. Krugman, S., Giles, J.P. and Hammond, J., Infective hepatitis:
Evidence for two distinctive clinical, epidemiological and immunological
types of infection, J. Am., Med. Assoc. (1967): 200, 365.
- Mahajan, R.K., Talib, V.H., Kelkar, S.S., Ergastric hepatitis—Laboratory
infection by hepatitis virus B. Ind.J. Med. Res. (1974):
62, 1789.
- Madhavan, T.V., Sundaravalli, N., Sriramachari, S. and Raju,
V.B., Hepatitis and cirrhosis in children. In seminar on infectious
hepatitis and study group on Australia antigen, I.C.M.R. Tech.
Rep. Series (1973): 24, 145.
- Mehta, N.R. and Acharya, P.T., Epidemiological study of an outbreak
of infective hepatitis in the hospital staff quarters, Baroda.
In Seminar of infectious hepatitis and study group in Australia
antigen. I.C.M.R. Tech. Rep. Series (1973): 24, 81.
- Melnick, J.L., In water borne urban hepatitis (Delhi epidemic):
Hepatitis frontier, Little Brown, Boston, 1957. p. 241.
- Mitra, D.K., Ashrafuddin, S., Talib, S.H., Liv.52 in viral hepatitis
with special reference to its use in precoma and coma. Probe
(1974): 14, 14.
- Prince, A.M. Hargrove, R.L., Szmuness, W., Cherubin, C.E., Fontans
V, J and Jeffries, G.M., Immunological distinction between infective
and serum hepatitis, New Engl. J. Med. (1970): 282, 987.
- Ramalingam, V., Sundaravalli, N. and Raju, V.B., Liv.52 studies
in acute hepatitis, Ind. Paediat. (1971): 8, 839.
- Rao, V.S., Reddy, Y.R. and Rohini, K., Viral hepatitis in children,
Ind. Paediat. (1975): 12, 659.
- Sundaravalli, N., Madhavan, T.V., Chowdhury, A.N.R., Sriramachari,
S. and Raju V.B., Detection of Australia antigen in Indian childhood
cirrhosis, Indian Paediat. (1971): 8, 365.
- Sama, S.K., Anand, S., Malaviya, A.S., Gandhi, P.C. and Tandon,
B.N., Australia/SH antigen in normal population and patients of
viral hepatitis in Delhi, Ind. J. Med. Res. (1971): 59,
64.
- Sehgal, S. and Aikat, B.K., 1970, Hepatitis associated antigen
in the sera of patients and blood donors, Ind. J. Med. Res.
(1973): 58, 1400.
- 26. Sule, C.R., Puri, V.R., Damania, R.F. and Joshi, V.S., Studies
with Liv.52 therapy in infective hepatitis, J. Ind. Med. Prof.
(1968): 12, 6391.
- Sutnick, A.I., London, W.T., Millman, I., Gerstely, B.S. and
Blumberg, B.B., Ergastric hepatitis, endemic hepatitis associated
with Australia antigen in a research laboratory, Ann. Intern.
med. (1971): 75, 35.
- Vakil, B.J., Role of corticosteroids in the treatment of viral
hepatitis, Ind. Council of Med. Res. Tech. Rep. Series (1973):
24, 112.
- Vakil, B.J., Aiyer, S.N., Shah, S.C., Gadgil, R.K. and Wagholikar,
U.N., A controlled trial of prednisolone in the treatment of infective
hepatitis, J. Ind. Med. Assoc. (1965): 45, 357.
- Vishwanathan, R., epidemiology of infective hepatitis, Probe
(1957): 45, 101.
|
Liv.52 |